{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:08:45Z","timestamp":1788307725417,"version":"build-2803163510"},"reference-count":16,"publisher":"The Pediatric Pharmacy Association","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"abstract":"<jats:p>Serotonin discontinuation syndrome (SDS) can result in a constellation of symptoms exhibited by infants exposed to selective serotonin reuptake inhibitors or other psychotropic drugs during pregnancy. Currently, there is no consensus regarding the pharmacologic management of SDS. We report our experience with clonidine for the management of a term infant with poor neonatal adaption. The infant exhibited biphasic symptoms of acute toxicity at birth and a plateauing of symptoms, followed by subsequent withdrawal symptomatology requiring the use of clonidine in doses up to 4 mcg\/kg\/dose every 3 hours for control of symptoms. The 38-week gestation Caucasian male infant was born to a mother with major depressive disorder, which was managed with sertraline, trazodone, venlafaxine, and buspirone throughout her pregnancy. The infant exhibited severe hypertonia at delivery and continued to have hypertonia, tremors, hypoglycemia, and feeding issues upon admission to the NICU. The initial Modified Finnegan Neonatal Abstinence scores were extremely elevated, and clonidine was started at 1 mcg\/kg\/dose every 3 hours and then the dose was titrated up to 4 mcg\/kg\/dose. This is the first report documenting the use of clonidine to manage serotonin toxicity at birth followed by subsequent neonatal withdrawal associated with maternal antidepressant drug use during pregnancy.<\/jats:p>","DOI":"10.5863\/1551-6776-26.5.502","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T22:44:49Z","timestamp":1624920289000},"page":"502-517","source":"Crossref","is-referenced-by-count":4,"title":["Serotonin Toxicity Versus Withdrawal: Clonidine One Size Fits All?"],"prefix":"10.5863","volume":"26","author":[{"given":"Jordan","family":"Burdine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Luedtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","reference":[{"issue":"1","key":"i1551-6776-26-5-502-b1","series-title":"Ginekol Pol","first-page":"36","article-title":"Effect of antidepressants use in pregnancy on foetus development and adverse effects in newborns","volume":"88","year":"2017","unstructured":"Ba\u0142kowiec-Iskra\n              E,\n            \n            \n              Mirowska-Guzel\n              DM,\n            \n            \n              Wielgo\u015b\n              M.\n            \n          \n          Effect of antidepressants use in pregnancy on foetus development and adverse effects in newborns.\n\t\t\t\t\tGinekol Pol.\n\t\t\t\t\t2017;\n\t\t\t\t\t88(\n\t\t\t\t\t1):\n\t\t\t\t\t36\u2013\n\t\t\t\t\t42."},{"issue":"12","key":"i1551-6776-26-5-502-b2","series-title":"PLoS ONE","doi-asserted-by":"publisher","first-page":"e0168115","DOI":"10.1371\/journal.pone.0168115","article-title":"Is the risk of preterm birth and low birth weight affected by the use of antidepressant agents during pregnancy? A population-based investigation","volume":"11","year":"2016","unstructured":"Cantarutti\n              A,\n            \n            \n              Merlino\n              L,\n            \n            \n              Monzani\n              E,\n            \n          \n          .\n\t\t\t\t\tIs the risk of preterm birth and low birth weight affected by the use of antidepressant agents during pregnancy? A population-based investigation.\n\t\t\t\t\tPLoS ONE.\n\t\t\t\t\t2016;\n\t\t\t\t\t11(\n\t\t\t\t\t12):\n\t\t\t\t\te0168115.\n\t\t\t\t\tdoi:10.1371\/journal.pone.0168115"},{"issue":"2","key":"i1551-6776-26-5-502-b3","series-title":"Drug Saf","first-page":"94","article-title":"The serotonin syndrome. Implicated drugs, pathophysiology and management","volume":"13","year":"1995","unstructured":"Sporer\n              KA.\n            \n          \n          The serotonin syndrome. Implicated drugs, pathophysiology and management.\n\t\t\t\t\tDrug Saf.\n\t\t\t\t\t1995;\n\t\t\t\t\t13(\n\t\t\t\t\t2):\n\t\t\t\t\t94\u2013\n\t\t\t\t\t104."},{"issue":"5","key":"i1551-6776-26-5-502-b4","series-title":"Pediatrics","first-page":"e20160181","article-title":"Neonatal morbidity after maternal use of antidepressant drugs during pregnancy","volume":"138","year":"2016","unstructured":"N\u00f6rby\n              U,\n            \n            \n              Forsberg\n              L,\n            \n            \n              Wide\n              K,\n            \n          \n          .\n\t\t\t\t\tNeonatal morbidity after maternal use of antidepressant drugs during pregnancy.\n\t\t\t\t\tPediatrics.\n\t\t\t\t\t2016;\n\t\t\t\t\t138(\n\t\t\t\t\t5):\n\t\t\t\t\te20160181.\n\t\t\t\t\tdoi:10.1542\/peds.2016-0181"},{"issue":"2","key":"i1551-6776-26-5-502-b5","series-title":"Arch Pediatr Adolesc Med","first-page":"173","article-title":"Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants","volume":"160","year":"2006","unstructured":"Levinson-Castiel\n              R,\n            \n            \n              Merlob\n              P,\n            \n            \n              Linder\n              N,\n            \n          \n          .\n\t\t\t\t\tNeonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.\n\t\t\t\t\tArch Pediatr Adolesc Med.\n\t\t\t\t\t2006;\n\t\t\t\t\t160(\n\t\t\t\t\t2):\n\t\t\t\t\t173\u2013\n\t\t\t\t\t176."},{"issue":"11","key":"i1551-6776-26-5-502-b6","series-title":"N Engl J Med","first-page":"1112","article-title":"The serotonin syndrome","volume":"352","year":"2005","unstructured":"Boyer\n              EW,\n            \n            \n              Shannon\n              M.\n            \n          \n          The serotonin syndrome.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t2005;\n\t\t\t\t\t352(\n\t\t\t\t\t11):\n\t\t\t\t\t1112\u2013\n\t\t\t\t\t1120."},{"issue":"3","key":"i1551-6776-26-5-502-b7","series-title":"Acta Paediatr","first-page":"288","article-title":"Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors","volume":"90","year":"2001","unstructured":"Nordeng\n              H,\n            \n            \n              Lindemann\n              R,\n            \n            \n              Perminov\n              KV,\n            \n            \n              Reikvam\n              A.\n            \n          \n          Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors.\n\t\t\t\t\tActa Paediatr.\n\t\t\t\t\t2001;\n\t\t\t\t\t90(\n\t\t\t\t\t3):\n\t\t\t\t\t288\u2013\n\t\t\t\t\t291."},{"key":"i1551-6776-26-5-502-b8","series-title":"Current Therapy in Neonatal-Perinatal Medicine","first-page":"317","article-title":"Neonatal abstinence syndrome: assessment and pharmacotherapy","year":"1990","unstructured":"Finnegan\n              LP.\n            \n          \n          Neonatal abstinence syndrome: assessment and pharmacotherapy.\n\t\t\t\t\tIn:NelsonN,ed.Current Therapy in Neonatal-Perinatal Medicine.\n\t\t\t\t\t2nd ed.\n\t\t\t\t\tOntario, British Columbia, Canada:\n\t\t\t\t\tDecker;\n\t\t\t\t\t1990:\n\t\t\t\t\t317."},{"issue":"9","key":"i1551-6776-26-5-502-b9","series-title":"Aust N Z J Psychiatr","first-page":"846","article-title":"Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study","volume":"43","year":"2009","unstructured":"Galbally\n              M,\n            \n            \n              Lewis\n              AJ,\n            \n            \n              Lum\n              J,\n            \n            \n              Buist\n              A.\n            \n          \n          Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study.\n\t\t\t\t\tAust N Z J Psychiatr.\n\t\t\t\t\t2009;\n\t\t\t\t\t43(\n\t\t\t\t\t9):\n\t\t\t\t\t846\u2013\n\t\t\t\t\t854."},{"issue":"suppl 4","key":"i1551-6776-26-5-502-b10","series-title":"J Clin Psychiatr","first-page":"8","article-title":"Physiologic mechanisms underlying the antidepressant discontinuation syndrome","volume":"67","year":"2006","unstructured":"Blier\n              P,\n            \n            \n              Tremblay\n              P.\n            \n          \n          Physiologic mechanisms underlying the antidepressant discontinuation syndrome.\n\t\t\t\t\tJ Clin Psychiatr.\n\t\t\t\t\t2006;\n\t\t\t\t\t67(\n\t\t\t\t\tsuppl 4):\n\t\t\t\t\t8\u2013\n\t\t\t\t\t13."},{"issue":"2","key":"i1551-6776-26-5-502-b11","series-title":"Pediatrics","first-page":"e547","article-title":"Neonatal abstinence syndrome","volume":"134","year":"2014","unstructured":"Kocherlakota\n              P.\n            \n          \n          Neonatal abstinence syndrome.\n\t\t\t\t\tPediatrics.\n\t\t\t\t\t2014;\n\t\t\t\t\t134(\n\t\t\t\t\t2):\n\t\t\t\t\te547\u2013\n\t\t\t\t\te561."},{"issue":"5","key":"i1551-6776-26-5-502-b12","series-title":"Pediatrics","first-page":"e849","article-title":"Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial","volume":"123","year":"2009","unstructured":"Agthe\n              AG,\n            \n            \n              Kim\n              GR,\n            \n            \n              Mathias\n              KB,\n            \n          \n          .\n\t\t\t\t\tClonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.\n\t\t\t\t\tPediatrics.\n\t\t\t\t\t2009;\n\t\t\t\t\t123(\n\t\t\t\t\t5):\n\t\t\t\t\te849\u2013\n\t\t\t\t\te856."},{"issue":"5","key":"i1551-6776-26-5-502-b13","series-title":"J Perinatol","first-page":"374","article-title":"Opioids and clonidine modulate cytokine production and opioid receptor expression in neonatal immune cells","volume":"33","year":"2013","unstructured":"Chavez-Valdez\n              R,\n            \n            \n              Kovell\n              L,\n            \n            \n              Ahlawat\n              R,\n            \n          \n          .\n\t\t\t\t\tOpioids and clonidine modulate cytokine production and opioid receptor expression in neonatal immune cells.\n\t\t\t\t\tJ Perinatol.\n\t\t\t\t\t2013;\n\t\t\t\t\t33(\n\t\t\t\t\t5):\n\t\t\t\t\t374\u2013\n\t\t\t\t\t382."},{"issue":"8","key":"i1551-6776-26-5-502-b14","series-title":"Acta Anaesthesiol Scand","first-page":"1058","article-title":"Clonidine abolishes the adverse effects on apoptosis and behaviour after neonatal ketamine exposure in mice","volume":"56","year":"2012","unstructured":"Pont\u00e9n\n              E,\n            \n            \n              Viberg\n              H,\n            \n            \n              Gordh\n              T,\n            \n          \n          .\n\t\t\t\t\tClonidine abolishes the adverse effects on apoptosis and behaviour after neonatal ketamine exposure in mice.\n\t\t\t\t\tActa Anaesthesiol Scand.\n\t\t\t\t\t2012;\n\t\t\t\t\t56(\n\t\t\t\t\t8):\n\t\t\t\t\t1058\u2013\n\t\t\t\t\t1065."},{"issue":"6","key":"i1551-6776-26-5-502-b15","series-title":"Clin Toxicol","first-page":"551","article-title":"Use of clonidine in the prevention and management of neonatal abstinence syndrome","volume":"47","year":"2009","unstructured":"Leikin\n              JB,\n            \n            \n              Mackendrick\n              WP,\n            \n            \n              Maloney\n              GE,\n            \n          \n          .\n\t\t\t\t\tUse of clonidine in the prevention and management of neonatal abstinence syndrome.\n\t\t\t\t\tClin Toxicol.\n\t\t\t\t\t2009;\n\t\t\t\t\t47(\n\t\t\t\t\t6):\n\t\t\t\t\t551\u2013\n\t\t\t\t\t555."},{"issue":"7\u20138","key":"i1551-6776-26-5-502-b16","series-title":"Ann Pharmacother","first-page":"1342","article-title":"Treatment of neonatal withdrawal with clonidine after long term, high-dose maternal use of tramadol","volume":"44","year":"2010","unstructured":"O'Mara\n              K,\n            \n            \n              Gal\n              P,\n            \n            \n              DaVanzo\n              C.\n            \n          \n          Treatment of neonatal withdrawal with clonidine after long term, high-dose maternal use of tramadol.\n\t\t\t\t\tAnn Pharmacother.\n\t\t\t\t\t2010;\n\t\t\t\t\t44(\n\t\t\t\t\t7\u20138):\n\t\t\t\t\t1342\u2013\n\t\t\t\t\t1344."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/26\/5\/article-p502.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/26\/5\/502\/2855322\/i1551-6776-26-5-502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/26\/5\/article-p502.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/26\/5\/article-p502.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:45:53Z","timestamp":1747356353000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/26\/5\/article-p502.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":16,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-26.5.502","relation":{},"ISSN":["1551-6776"],"issn-type":[{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}